HealthLumen reposted this
🧑🔬 Amanda Hayward, Head of Global Business Development presented our research, in partnership with HealthLumen, on quantifying the proportion of women at risk of an FNAIT pregnancy in diverse populations in the United States at NORD today. The study reveals key findings on fetal/neonatal alloimmune thrombocytopenia (FNAIT) risk across diverse ancestries for the first time. ˃˃ Using genetic data, researchers found that nearly 20,000 pregnancies in the U.S. are at higher risk for FNAIT each year—far more than previously estimated. ˃˃ The study highlights that non-White populations also carry significant FNAIT risk, challenging past assumptions. ˃˃ These findings make a compelling case for universal screening of pregnant women for FNAIT risk, regardless of race or ethnicity, and we’re proud to play a part in advocating for a future where this is the norm. #HealthEquity #FNAIT #MaternalHealth #NORD #NORD24